QOP
MED icon

Quinn Opportunity Partners’s Medifast MED Stock Holding History

Quinn Opportunity Partners’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.3M Hold
127,112
– – 0.07% 194
2025
Q4 		$1.36M Hold
127,112
– – 0.06% 202
2025
Q3 		$1.74M Hold
127,112
– – 0.12% 151
2025
Q2 		$1.79M Buy
127,112
+4,940
+4% +$64.9K 0.15% 142
2025
Q1 		$1.65M Buy
122,172
+50,565
+71% +$759K 0.11% 178
2024
Q4 		$1.26M Sell
71,607
-45,378
-39% -$842K 0.09% 182
2024
Q3 		$2.24M Buy
+116,985
New +$2.25M 0.22% 99

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $403M AUM 43.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Quinn Opportunity Partners's MED Position: Q1 2026 in Review

Quinn Opportunity Partners held its Medifast (MED) position steady in Q1 2026 at 127,112 shares worth $1.3M. The position accounts for 0.07% of the portfolio, ranked #194.

Quinn Opportunity Partners first reported a position in MED in Q3 2024 and has held it in 7 quarters since. The position peaked at $2.24M in Q3 2024. 111 funds tracked by Wall St. Rank hold MED as of Q1 2026.

  • Quinn Opportunity Partners held 127,112 shares of Medifast worth $1.3M as of Q1 2026.
  • Quinn Opportunity Partners left its Medifast share count unchanged in Q1 2026.
  • Medifast made up 0.07% of Quinn Opportunity Partners's portfolio in Q1 2026, its #194 holding.
  • Quinn Opportunity Partners first reported a position in Medifast in Q3 2024 and has held it in 7 quarters since.
  • Quinn Opportunity Partners's Medifast position peaked at $2.24M in Q3 2024.
  • 111 funds tracked by Wall St. Rank held Medifast as of Q1 2026.

Based on Quinn Opportunity Partners's 13F filing for Q1 2026, filed 15 May 2026.